USFDA APPLICATION NUMBER - 206619 / DOSAGE - TABLET;ORAL - EQ 250MG BASE;12.5MG, 75MG, 50MG
Inactive Ingredients
Ingredient Name | AbbVie Inc. |
---|---|
COPOVIDONE K25-31(D9C330MD8B) | |
CROSCARMELLOSE SODIUM(M28OL1HH48) | |
FERRIC OXIDE RED(1K09F3G675) | |
FERRIC OXIDE YELLOW(EX438O2MRT) | |
FERROSOFERRIC OXIDE(XM0M87F357) | |
LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
MAGNESIUM STEARATE(70097M6I30) | |
MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
POLYETHYLENE GLYCOL 3350(G2M7P15E5P) | |
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |
PROPYLENE GLYCOL LAURATES(40KT317HGP) | |
SILICON DIOXIDE(ETJ7Z6XBU4) | |
SODIUM STEARYL FUMARATE(7CV7WJK4UI) | |
SORBITAN MONOLAURATE(6W9PS8B71J) | |
TALC(7SEV7J4R1U) | |
TITANIUM DIOXIDE(15FIX9V2JP) | |
TOCOPHERSOLAN(O03S90U1F2) |
LOOKING FOR A SUPPLIER?